» Articles » PMID: 37851166

Salidroside Suppresses Cell Growth and Inflammatory Response of Fibroblast-like Synoviocytes Via Inhibition of Phosphoinositol-3 Kinase/threonine Kinase Signaling in Rheumatoid Arthritis

Overview
Journal Z Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2023 Oct 18
PMID 37851166
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Salidroside (Sal) is a natural product commonly isolated from Rhodiola rosea L., which has been found to have numerous pharmacological activities (e.g., ameliorating apoptosis and inflammation, and acting as an antioxidant) in various diseases, but its concrete function in rheumatoid arthritis (RA) has not been revealed yet. Here, we aimed to explore the specific role and underlying mechanisms of Sal in RA-fibroblast-like synoviocytes (RA-FLSs).

Methods: Cell counting kit 8 (CCK-8) was used to assess the viability of normal-FLSs and RA-FLSs. Cell apoptosis in RA-FLSs was evaluated by flow cytometry. Western blotting was prepared to examine the levels of apoptosis- and signaling-related proteins. Wound-healing and Transwell assays were conducted to examine RA-FLSs migration and invasion. Enzyme-linked immunosorbent assay (ELISA) was used to assess the effect of Sal on tumor necrosis factor-alpha (TNF-α)-induced inflammation in RA-FLSs. RA animal model was established through complete Freund's adjuvant (CFA) induction, and the histopathological changes in synovial tissues of the rat model were analyzed by H&E staining.

Results: RA-FLSs were treated with 200 μM Sal for 24 h, and cell viability was significantly suppressed. Sal promoted RA-FLSs apoptosis. The migratory and invasive abilities of RA-FLSs were markedly inhibited by Sal. Sal incubation reduced the levels of inflammatory cytokines interleukin‑8 (IL-8), IL-1β, and IL‑6 in RA-FLSs under the stimulation of TNF‑α. Subsequently, Sal downregulated phosphorylated phosphatidylinositol‑3 kinase (p-PI3K) and protein kinase (p-AKT) expression in RA-FLSs. After the treatment with pathway activator 740Y‑P (20 μM) in RA-FLSs, the promotive effect of Sal on cell apoptosis was reversed, and inhibitory effects of it on cell viability, migration, invasion, and inflammatory response were abolished. Sal inhibited RA development in the CFA-induced rat model.

Conclusion: Sal suppressed cell growth and inflammation in RA-FLSs by inactivating PI3K/AKT-signaling pathways.

Citing Articles

Exploring the therapeutic potential of "Tianyu" medicine pair in rheumatoid arthritis: an integrated study combining LC-MS/MS, bioinformatics, network pharmacology, and experimental validation.

Tang L, Guo D, Jia D, Piao S, Fang C, Zhu Y Front Med (Lausanne). 2024; 11:1475239.

PMID: 39430588 PMC: 11488520. DOI: 10.3389/fmed.2024.1475239.


Salidroside: A Promising Agent in Bone Metabolism Modulation.

Wojdasiewicz P, Brodacki S, Cieslicka E, Turczyn P, Poniatowski L, Lawniczak W Nutrients. 2024; 16(15).

PMID: 39125268 PMC: 11314424. DOI: 10.3390/nu16152387.


Mechanism of Rhodiola rosea-Euonymus alatus drug pair against rheumatoid arthritis: Network pharmacology and experimental validation.

Zheng Q, Du L, Zhao Y, Zhang Z, Piao S, Wang Y Immun Inflamm Dis. 2023; 11(12):e1127.

PMID: 38156377 PMC: 10750436. DOI: 10.1002/iid3.1127.


Integrated Network Pharmacology and Experimental Approach to Investigate the Protective Effect of Jin Gu Lian Capsule on Rheumatoid Arthritis by Inhibiting Inflammation via IL-17/NF-κB Pathway.

Chen T, Li S, Lian D, Hu Q, Hou H, Niu D Drug Des Devel Ther. 2023; 17:3723-3748.

PMID: 38107658 PMC: 10725692. DOI: 10.2147/DDDT.S423022.

References
1.
Sparks J . Rheumatoid Arthritis. Ann Intern Med. 2019; 170(1):ITC1-ITC16. DOI: 10.7326/AITC201901010. View

2.
Bottini N, Firestein G . Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2012; 9(1):24-33. PMC: 3970924. DOI: 10.1038/nrrheum.2012.190. View

3.
Chen Z, Bozec A, Ramming A, Schett G . Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2018; 15(1):9-17. DOI: 10.1038/s41584-018-0109-2. View

4.
Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

5.
Korb-Pap A, Bertrand J, Sherwood J, Pap T . Stable activation of fibroblasts in rheumatic arthritis-causes and consequences. Rheumatology (Oxford). 2016; 55(suppl 2):ii64-ii67. DOI: 10.1093/rheumatology/kew347. View